Go Pro
→ SpaceX IPO hides a much bigger story (From Weiss Ratings) (Ad)tc pixel Free FBIOP Stock Alerts

Fortress Biotech (FBIOP) Competitors

Fortress Biotech logo
$20.10 +0.06 (+0.27%)
As of 12:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

FBIOP vs. ADTX, AIMDW, ALVOW, ARAV, and ACABW

Should you buy Fortress Biotech stock or one of its competitors? MarketBeat compares Fortress Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortress Biotech include Aditxt (ADTX), Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry.

How does Fortress Biotech compare to Aditxt?

Aditxt (NASDAQ:ADTX) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Fortress Biotech has a net margin of 0.00% compared to Aditxt's net margin of -360,152.50%. Fortress Biotech's return on equity of 0.00% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
Aditxt-360,152.50% -374.60% -105.93%
Fortress Biotech N/A N/A N/A

In the previous week, Aditxt had 4 more articles in the media than Fortress Biotech. MarketBeat recorded 6 mentions for Aditxt and 2 mentions for Fortress Biotech. Fortress Biotech's average media sentiment score of 1.44 beat Aditxt's score of 0.42 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Aditxt Neutral
Fortress Biotech Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aditxt
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Fortress Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Fortress Biotech has higher revenue and earnings than Aditxt.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aditxt$14.34K0.13-$41.71M-$100.79 thousandN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

15.5% of Aditxt shares are owned by institutional investors. 0.0% of Aditxt shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Fortress Biotech beats Aditxt on 5 of the 9 factors compared between the two stocks.

How does Fortress Biotech compare to Ainos?

Ainos (NASDAQ:AIMDW) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

In the previous week, Ainos and Ainos both had 2 articles in the media. Fortress Biotech's average media sentiment score of 1.44 beat Ainos' score of 1.43 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Ainos Positive
Fortress Biotech Positive

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Fortress Biotech N/A N/A N/A

Summary

Fortress Biotech beats Ainos on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$559.42MN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

In the previous week, Alvotech and Alvotech both had 2 articles in the media. Fortress Biotech's average media sentiment score of 1.44 beat Alvotech's score of 0.93 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Alvotech Positive
Fortress Biotech Positive

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Fortress Biotech N/A N/A N/A

Summary

Alvotech and Fortress Biotech tied by winning 1 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Aravive?

Fortress Biotech (NASDAQ:FBIOP) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

In the previous week, Fortress Biotech had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Fortress Biotech and 0 mentions for Aravive. Fortress Biotech's average media sentiment score of 1.44 beat Aravive's score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Fortress Biotech Positive
Aravive Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Aravive N/A N/A N/A

Summary

Fortress Biotech beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Fortress Biotech compare to Atlantic Coastal Acquisition Corp. II?

Fortress Biotech (NASDAQ:FBIOP) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, Fortress Biotech had 2 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 2 mentions for Fortress Biotech and 0 mentions for Atlantic Coastal Acquisition Corp. II. Fortress Biotech's average media sentiment score of 1.44 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Fortress Biotech Positive
Atlantic Coastal Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Summary

Fortress Biotech beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIOP vs. The Competition

Export
MetricFortress BiotechBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$499.35M$6.82B$12.35B
Dividend Yield12.11%3.87%2.67%6.11%
P/E RatioN/A3.1725.8224.22
Price / SalesN/A6,855.83551.75101.49
Price / CashN/A13.1329.0936.93
Price / BookN/A89.8410.906.43
Net IncomeN/A-$96.07M$3.58B$336.87M
7 Day Performance0.93%1.24%2.42%0.27%
1 Month Performance3.26%-0.14%0.14%-0.93%
1 Year Performance153.56%72.03%35.46%29.64%

Fortress Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIOP
Fortress Biotech
N/A$20.11
+0.3%		N/A+152.9%$0.00$66.16MN/A170
ADTX
Aditxt
0.989 of 5 stars		$0.00
-59.6%		N/A-100.0%$0.00N/AN/A60
AIMDW
Ainos
N/A$0.13
-12.4%		N/A-20.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.33
flat		N/AN/A$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:FBIOP) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel